Back to top

medical-devices: Archive

Zacks Equity Research

Medtronic (MDT) Gets Health Canada License for GI Genius Module

Medtronic Canada ULC, a subsidiary of Medtronic (MDT), receives Health Canada license for the GI Genius module that aids in colorectal cancer screening.

MDTNegative Net Change OMCLNo Net Change VREXNegative Net Change NXGNNegative Net Change

Zacks Equity Research

Walgreens (WBA) Buys Remaining Stake in German Wholesale Business

Walgreens' (WBA) recent acquisition of the remaining ownership stake helps the company to further solidify its position as a leading pharmaceutical wholesaler in Germany.

LHNegative Net Change MCKNegative Net Change WBANegative Net Change MEDPNegative Net Change

Zacks Equity Research

DaVita (DVA) Study Favors mRNA Vaccines for Dialysis Patients

DaVita's (DVA) latest study indicates favorable outcomes for ESKD patients regarding the COVID-19 vaccines.

DVANegative Net Change TMONegative Net Change WSTNegative Net Change CHENegative Net Change

Zacks Equity Research

Here's Why You Should Hold on to Glaukos (GKOS) Stock Now

Glaukos Corporation (GKOS) continues to benefit from a robust product portfolio and solid performing iStent technology.

ANGONegative Net Change TMONegative Net Change MCKNegative Net Change GKOSNegative Net Change

Zacks Equity Research

OPKO Health's (OPK) Arm Declares Readiness for COVID-19 Testing

OPKO Health's (OPK) BioReference Laboratories announces preparedness with respect to COVID-19 testing in the advent of the Omicron Variant.

ANGONegative Net Change TMONegative Net Change MCKNegative Net Change OPKNegative Net Change

Zacks Equity Research

Best Momentum Stocks to Buy for November 30th

VSTO, SRTS, PLCE, and NMRK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 30, 2021.

PLCENegative Net Change VSTONegative Net Change SRTSPositive Net Change NMRKNegative Net Change

Zacks Equity Research

Here's Why You Should Invest In Bruker (BRKR) Stock for Now

Investors are optimistic about Bruker's (BRKR) better-than-expected results and strong segmental performance.

OMCLNo Net Change WSTNegative Net Change BRKRNegative Net Change VREXNegative Net Change

Zacks Equity Research

QIAGEN (QGEN), DiaSorin to Broaden Access to Latent TB Testing

QIAGEN (QGEN) and DiaSorin gained FDA approval for their jointly-created LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated LIAISON XS platform.

OMCLNo Net Change QGENNegative Net Change WSTNegative Net Change VREXNegative Net Change

Zacks Equity Research

Masimo's (MASI) Rad-G Clinical Study Trial Outcome Favorable

Masimo's (MASI) latest study results demonstrate that Rad-G Pulse Oximeter can help detect pediatric pneumonia.

LHNegative Net Change MASINegative Net Change CHENegative Net Change MEDPNegative Net Change

Zacks Equity Research

3 Reasons to Retain Integer Holdings (ITGR) Stock For Now

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and its focus on growth strategies.

TMONegative Net Change WSTNegative Net Change CHENegative Net Change ITGRNegative Net Change

Zacks Equity Research

Here's Why You Should Retain DENTSPLY SIRONA (XRAY) Now

DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, forex woe persists.

ANGONegative Net Change TMONegative Net Change MCKNegative Net Change XRAYPositive Net Change

Zacks Equity Research

SeaSpine (SPNE) Enhances ACDF Procedure With Admiral ACP System

SeaSpine's (SPNE) next-generation Admiral ACP System covers the largest segment in the estimated $1.30-billion cervical spine surgery market.

LHNegative Net Change CHENegative Net Change MEDPNegative Net Change SPNEPositive Net Change

Zacks Equity Research

Here's Why You Should Hold on to Globus Medical (GMED) for Now

Investors are optimistic about Globus Medical's (GMED) better-than-expected earnings and robust ExcelsiusGPS performance.

OMCLNo Net Change WSTNegative Net Change GMEDNegative Net Change VREXNegative Net Change

Zacks Equity Research

Here's Why You Should Add Hill-Rom (HRC) to Your Portfolio

Investors are optimistic about Hill-Rom (HRC) on strong fiscal fourth-quarter results and progress in digital health.

LHNegative Net Change HRCPositive Net Change CHENegative Net Change MEDPNegative Net Change

Urmimala Biswas

Quest Diagnostics' (DGX) COVID-19 Testing Demand Up in 3 Weeks

According to Quest Diagnostics (DGX), as the nation is entering the holiday season, the importance of testing service is gaining more importance with regard to minimizing the risk of community exposure of COVID-19.

ANGONegative Net Change DGXNegative Net Change TMONegative Net Change MCKNegative Net Change

Zacks Equity Research

Here's Why You Should Retain Abbott (ABT) Stock For Now

Investors are optimistic about Abbott (ABT) owing to strong third-quarter results and bullish 2021 outlook.

ABTNegative Net Change LHNegative Net Change CHENegative Net Change MEDPNegative Net Change

Zacks Equity Research

Here's Why You Should Retain ResMed (RMD) Stock for Now

Investors are optimistic about ResMed (RMD) given its better-than-expected results and robust SaaS business performance in the fiscal first quarter.

OMCLNo Net Change RMDNegative Net Change AMNNegative Net Change VREXNegative Net Change

Zacks Equity Research

Cooper Companies (COO) to Post Q4 Earnings: What's in Store?

Cooper Companies' (COO) fiscal fourth-quarter results are likely to reflect segmental strength.

ANGONegative Net Change TMONegative Net Change COONegative Net Change MEDPNegative Net Change

Zacks Equity Research

Bio Rad (BIO) Grows Internationally on New Product Launches

Strength in Bio Rad's (BIO) key product lines across major geographic regions buoys optimism.

LHNegative Net Change BIOPositive Net Change CHENegative Net Change MEDPNegative Net Change